Back
Speaker illustration

Doctor Stephanie Schwarting

Ludwig Maximilians University, Munich (Germany)

Member of:

European Society of Cardiology

Board certified cardiologist with expertise in cardiac infiltrative disease (amyloidosis) and cardiovascular imaging (echocardiography & CMR). Member of International Society of Amyloidosis, Cardiac Transthyretin Amyloidosis Fellowship of ISA 2023/2024. Research areas: ATTR-Cardiomyopathy, echocardiography

Presentations

Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: TAVI and aortic stenosis

Access
Like
Thumbnail

Impaired right ventricular free wall strain predicts mortality in patients with stabilizer-treated transthyretin amyloid cardiomyopathy.

Event: ESC Congress 2025

Topic: Infiltrative Myocardial Disease

Session: Prognostication and treatment of transthyretin cardiac amyloidosis

Access
Like
Thumbnail

RV-PA uncoupling is a strong predictor of 3-year all-cause mortality in transthyretin amyloid cardiomyopathy.

Event: ESC Congress 2024

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis: diagnosis and outcomes

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources